Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
LQDA Liquidia Corp
- Stocks
- Healthcare
- NASDAQ: LQDA
Price (delayed)
$15.35
Market cap
$1.31B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.58
Enterprise value
$1.29B
Liquidia Corporation is a biopharmaceutical company focused on the development and commercialization of products in pulmonary hypertension and other applications of its PRINT technology. The Company operates through two subsidiaries,
Highlights
Liquidia's EPS has decreased by 11% YoY but it has increased by 4.8% QoQ
The company's debt has surged by 69% YoY and by 23% QoQ
The quick ratio has shrunk by 61% YoY and by 34% QoQ
Key stats
What are the main financial stats of LQDA
Market
Valuations
Earnings
Shares outstanding
85.48M
Market cap
$1.31B
Enterprise value
$1.29B
Price to earnings (P/E)
N/A
Price to book (P/B)
26.34
Price to sales (P/S)
92.44
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
91.21
Revenue
$14.14M
Gross profit
$8.22M
Operating income
-$127.92M
Net income
-$127.83M
EBIT
-$113.2M
EBITDA
-$110.63M
Free cash flow
-$103.88M
Per share
Balance sheet
Liquidity
EPS
-$1.58
EPS diluted
-$1.58
Free cash flow per share
-$1.22
Book value per share
$0.58
Revenue per share
$0.17
TBVPS
$2.59
Total assets
$227.43M
Total liabilities
$177.72M
Debt
$147.67M
Equity
$49.71M
Working capital
$116.69M
Debt to equity
2.97
Current ratio
2.93
Quick ratio
2.83
Net debt/EBITDA
0.2
Margins
Efficiency
Dividend
EBITDA margin
-782.2%
Gross margin
58.1%
Net margin
-903.8%
Operating margin
-904.4%
Return on assets
-57.6%
Return on equity
-169.1%
Return on invested capital
-92.8%
Return on capital employed
-67.8%
Return on sales
-800.3%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
LQDA stock price
How has the Liquidia stock price performed over time
Intraday
-1.16%
1 week
9.8%
1 month
28.02%
1 year
22.8%
YTD
30.53%
QTD
4.07%
Financial performance
How have Liquidia's revenue and profit performed over time
Revenue
$14.14M
Gross profit
$8.22M
Operating income
-$127.92M
Net income
-$127.83M
Gross margin
58.1%
Net margin
-903.8%
The company's operating margin has shrunk by 55% YoY and by 4.4% QoQ
The company's net margin fell by 49% YoY but it rose by 3% QoQ
LQDA's operating income is down by 38% year-on-year and by 5% since the previous quarter
LQDA's gross profit is down by 33% year-on-year
Price vs fundamentals
How does LQDA's price correlate with its fundamentals
Growth
What is Liquidia's growth rate over time
Valuation
What is Liquidia stock price valuation
P/E
N/A
P/B
26.34
P/S
92.44
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
91.21
Liquidia's EPS has decreased by 11% YoY but it has increased by 4.8% QoQ
The stock's P/B is 77% above its last 4 quarters average of 14.9
LQDA's equity is down by 42% year-on-year and by 37% since the previous quarter
The stock's price to sales (P/S) is 114% more than its 5-year quarterly average of 43.1 and 39% more than its last 4 quarters average of 66.7
LQDA's revenue is down by 11% YoY
Efficiency
How efficient is Liquidia business performance
Liquidia's return on sales has decreased by 44% YoY but it has increased by 5% QoQ
The ROIC has grown by 31% YoY and by 12% from the previous quarter
The ROA has grown by 18% YoY and by 5% from the previous quarter
The ROE has contracted by 10% from the previous quarter and by 6% YoY
Dividends
What is LQDA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for LQDA.
Financial health
How did Liquidia financials performed over time
The total assets is 28% more than the total liabilities
Liquidia's current ratio has shrunk by 62% YoY and by 34% QoQ
The quick ratio has shrunk by 61% YoY and by 34% QoQ
The company's debt is 197% higher than its equity
The debt to equity has soared by 191% YoY and by 95% from the previous quarter
The company's debt has surged by 69% YoY and by 23% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.